CRF Inc. to Provide Allergan Global Electronic Patient Diary Technology.WALTHAM Waltham (wôl`thăm, –thəm), city (1990 pop. 57,878), Middlesex co., E Mass., a suburb of Boston, on the Charles River; settled c.1634, set off from Watertown 1738, inc. as a city 1884. , Mass. & HELSINKI, Finland -- CRF CRF abbr. chronic renal failure CRF Chronic renal failure Inc., the leading global provider of electronic Patient Diaries A Patient Diary is a tool used during a clinical trial or a disease treatment to measure treatment compliance. An Electronic Patient Diary registers the diary in a storage device and allows for monitoring the time the medication was taken. (e-Diaries) and wireless data collection solutions for the biopharmaceutical industry, announced today that Allergan has chosen CRF Inc's award-winning TrialMax Electronic Patient Reported Outcomes (ePRO) solution for use in Allergan's upcoming multinational clinical trials. "We are very pleased Allergan has decided to make CRF Inc. part of their clinical trial team. They have a long and well-established standard of excellence in drug discovery and development. TrialMax will support Allergan to capture higher quality data on efficacy, quality of life, safety and medication intake data," said Pamela McNamara, Chief Executive Officer of CRF Inc. "We believe in providing our customers the highest level of customer service and care and look forward to a productive working relationship with Allergan." "We anticipate that the TrialMax e-Diary solution will effectively provide our clinical teams with advanced ePRO technology combined with CRF Inc.'s outstanding global deployment and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services ," comments Ramzi Najm, Senior Director, Research and Development Information Systems. "We are confident that high compliance and patient acceptance rates will ensure outstanding patient diary data accuracy in our clinical trial work." About CRF Inc. CRF Inc. is the leading global provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the biopharmaceutical industry. Through innovative technology and a thorough understanding of drug development and mobile computing Using a computing device while in transit. Mobile computing implies wireless transmission, but wireless transmission does not necessarily imply mobile computing. Fixed wireless applications use satellites, radio systems and lasers to transmit between permanent objects such as buildings , the company is driving the change to safer and more efficient paper-free clinical trials. CRF Inc.'s technology has been used by more than 86,000 patients across 55 countries in 42 languages for 32 indications. The company has demonstrated the industry's highest patient compliance rates -- an average 95 percent compliance through Phase I, II, III and IV clinical trials -- and unmatched patient and research site acceptance. CRF Inc.'s award-winning product, TrialMax, is a flexible and customizable ePRO technology that provides real-time 1. real-time - Describes an application which requires a program to respond to stimuli within some small upper limit of response time (typically milli- or microseconds). Process control at a chemical plant is the classic example. patient monitoring, outstanding data accuracy and increased safety. Its unique features enable clinical trial sponsors to collect more valuable data faster and conduct complex clinical trials with greater flexibility than other ePRO solutions. CRF Inc.'s experience combined with its dedication to ensuring the highest quality and most responsive customer service has made the company the biopharmaceutical industry's most trusted partner. About Allergan Allergan, Inc., with headquarters in Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). , is a global specialty pharmaceutical company that develops and commercializes innovative products for the eye care, neuromodulator neuromodulator /neu·ro·mod·u·la·tor/ (-mod´u-la?ter) a substance, other than a neurotransmitter, released by a neuron and transmitting information to other neurons, altering their activities. , skin care and other specialty markets. In addition to its discovery-to-development research programs, Allergan has global marketing and sales capabilities in over 100 countries that deliver value to our customers, satisfy unmet un·met adj. Not satisfied or fulfilled: unmet demands. medical needs and improve people's lives. Driven by technology and innovation, Allergan addresses the needs of consumers across the world with over 5,000 employees worldwide, 4 world-class Research and Development facilities and 3 state-of-the-art manufacturing plants. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion